CIK 0001759138
- Non-accelerated filer
- Smaller reporting company
Cabaletta Bio, Inc.
Sign in to watch- Ticker
- CABA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-759-3100
- Business address
- 2929 ARCH STREET, SUITE 600, PHILADELPHIA, PA, 19104
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-09 | Simon Mark Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2026-01-21 | Simon Mark Director | Purchase | +11,061 | $2.28 | $25K | 147,205 |
| 2025-06-09 | Simon Mark Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-05-19 | Simon Mark Director | Returned to the company · Stock Option (Right to Buy) | −18,460 | 0 | ||
| 2025-05-19 | Simon Mark Director | Grant or award · Stock Option (Right to Buy) | +18,460 | 18,460 | ||
| 2025-05-19 | Simon Mark Director | Returned to the company · Stock Option (Right to Buy) | −22,000 | 0 | ||
| 2025-05-19 | Simon Mark Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-05-19 | Simon Mark Director | Returned to the company · Stock Option (Right to Buy) | −22,000 | 0 | ||
| 2025-05-19 | Simon Mark Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-05-19 | Simon Mark Director | Returned to the company · Stock Option (Right to Buy) | −22,000 | 0 | ||
| 2025-05-19 | Simon Mark Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2024-06-03 | Simon Mark Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2023-06-01 | Simon Mark Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2022-10-18 | Simon Mark Director | Purchase | +118,000 | $0.98 | $115K | 136,144 |
| 2022-10-18 | Simon Mark Director | Purchase | +7,000 | $0.98 | $7K | 7,000 |
| 2022-06-01 | Simon Mark Director | Grant or award · Stock Option (Right to buy) | +22,000 | 22,000 | ||
| 2021-06-01 | Simon Mark Director | Grant or award · Stock Option (Right to buy) | +22,000 | 22,000 | ||
| 2019-10-29 | Simon Mark Director | Conversion | +18,144 | 18,144 | ||
| 2019-10-29 | Simon Mark Director | Conversion · Series A-1 Preferred Stock | −27,217 | 0 |
Page 1 of 1 · 19 trades